Cargando…
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
Risk or presence of metastasis in medulloblastoma causes substantial treatment-related morbidity and overall mortality. Through the comparison of cytokines and growth factors in the cerebrospinal fluid (CSF) of metastatic medulloblastoma patients with factors also in conditioned media of metastatic...
Autores principales: | Svalina, Matthew N., Kikuchi, Ken, Abraham, Jinu, Lal, Sangeet, Davare, Monika A., Settelmeyer, Teagan P., Young, Michael C., Peckham, Jennifer L., Cho, Yoon-Jae, Michalek, Joel E., Hernandez, Brian S., Berlow, Noah E., Jackson, Melanie, Guillaume, Daniel J., Selden, Nathan R., Bigner, Darell D., Nazemi, Kellie J., Green, Sarah C., Corless, Christopher L., Gultekin, Sakir, Mansoor, Atiya, Rubin, Brian P., Woltjer, Randall, Keller, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891740/ https://www.ncbi.nlm.nih.gov/pubmed/27255663 http://dx.doi.org/10.1038/srep27012 |
Ejemplares similares
-
NFκB signaling in alveolar rhabdomyosarcoma
por: Cleary, Megan M., et al.
Publicado: (2017) -
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
por: Berlow, Noah E., et al.
Publicado: (2018) -
A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy
por: Halfpenny, Aaron, et al.
Publicado: (2019) -
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017) -
Defining the Extracellular Matrix of Rhabdomyosarcoma
por: Lian, Xiaolei, et al.
Publicado: (2021)